Shandong Keyuan Pharmaceutical Co., Ltd. (SZSE: 301281)
Health Care · Pharmaceuticals · CN
CN¥43.65
+5.46% today · +17.1% 1Y
Shandong Keyuan Pharmaceutical Co., Ltd. (SZSE: 301281) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $700.84M.
Over the last twelve months the share price has gained 17.1%, trading between 25.87 and 59.24.
Tweenvest scores Shandong Keyuan Pharmaceutical Co., Ltd. across four factors: quality 71/100, value 32/100, growth 4/100, dividend 15/100. Its strongest factor is quality.
301281 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $700.84M
- Revenue (TTM)
- $65.00M
- P/E
- 204.62
- EPS
- 0.21
- Dividend yield
- 0.11%
- Beta (5Y)
- 0.12
- 52-week high
- CN¥59.24
- 52-week low
- CN¥25.87
- Avg volume (3M)
- —
- Shares outstanding
- 108.29M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.